| WHO Novel Coronavirus (2019-nCoV) situation reports(世界卫生组织关于新冠病毒的情况介绍) |
WHO |
| Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV |
ECDC(欧洲疾控中心) |
| Personal protective equipment (PPE) needs in healthcare settings for the care of patients with suspected or confirmed novel coronavirus (2019-nCoV) |
ECDC(欧洲疾控中心) |
| Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 |
Emerg Microbes Infect (2020) 9 (1), 900-902 |
| Family medicine in times of \'COVID-19\': A generalists\' voice |
Eur J Gen Pract (2020) 26 (1), 58-60 |
| COVID-19: an FY1 on the frontline |
Med Educ Online (2020) 25 (1), 1759869 |
| Being a front-line dentist during the Covid-19 pandemic: a literature review |
Maxillofac Plast Reconstr Surg (2020) 42 (1), 12 |
| Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension |
Emerg Microbes Infect (2020) 9 (1), 757-760 |
| Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients |
Emerg Microbes Infect (2020) 9 (1), 761-770 |
| Clinical observation and management of COVID-19 patients |
Emerg Microbes Infect (2020) 9 (1), 687-690 |
| The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19 |
Emerg Microbes Infect (2020) 9 (1), 707-713 |
| Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 |
Emerg Microbes Infect (2020) 9 (1), 680-686 |
| No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 |
Emerg Microbes Infect (2020) 9 (1), 505-507 |
| Public's early response to the novel coronavirus-infected pneumonia |
Emerg Microbes Infect (2020) 9 (1), 534 |
| Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) |
Emerg Microbes Infect (2020) 9 (1), 582-585 |
| Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 |
Emerg Microbes Infect (2020) 9 (1), 601-604 |
| A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
Emerg Microbes Infect (2020) 9 (1), 558-570 |
| Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned |
Emerg Microbes Infect (2020) 9 (1), 597-600 |
| Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |
Emerg Microbes Infect (2020) 9 (1), 469-473 |
| Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes |
Emerg Microbes Infect (2020) 9 (1), 386-389 |
